+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Consensus guidelines in the management of branch duct intraductal papillary mucinous neoplasm: a cost-effectiveness analysis



Consensus guidelines in the management of branch duct intraductal papillary mucinous neoplasm: a cost-effectiveness analysis



Digestive Diseases and Sciences 55(3): 852-860



Based on consensus guidelines, surgical resection of branch duct intraductal papillary mucinous neoplasm (BD-IPMN) is indicated in patients with symptoms of cyst size >or=30 mm, intramural nodules, or dilated main pancreatic duct greater than 6 mm. The aim of this study was to determine the cost effectiveness of consensus guideline implementation in the management of BD-IPMN. We developed a decision analytic model to compare the costs and effectiveness of three management strategies for a cohort of 60-year-old patients with branch duct IPMN: (1) surveillance using consensus guidelines for surgical resection (surveillance strategy), (2) surgical resection based on symptoms without surveillance (no surveillance strategy), and (3) immediate surgery (surgery strategy). The primary outcomes were quality-adjusted life years (QALYs), cost, and incremental cost-effectiveness ratio (ICER). Sensitivity analysis was performed over a wide ranges of estimates. The no surveillance strategy was the least costly, but also the least effective, while the surgery strategy was the most costly and most effective. Compared to the no surveillance strategy, the surveillance strategy cost an additional $20,096 per QALY. The incremental cost-effectiveness ratio of the surgery strategy compared with the surveillance strategy was $132,436 per QALY. In a probabilistic sensitivity analysis, if society was willing to pay $50,000 per quality-adjusted life year gained, then 88.1% of patients using the surveillance strategy would be within budget. Immediate surgery is the most effective, but may be prohibitively expensive. The surveillance strategy is a cost-effective option compared to no surveillance.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052303377

Download citation: RISBibTeXText

PMID: 19834805

DOI: 10.1007/s10620-009-1014-y


Related references

S1290 The Management of Branch Duct Intraductal Papillary Mucinous Neoplasm: A Cost-Effectiveness Analysis. Gastroenterology 136(5): A-230, 2009

Pancreatic-duct-lavage cytology in candidates for surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas: should the International Consensus Guidelines be revised?. Gastrointestinal Endoscopy 69(3 Pt 1): 434-440, 2009

Evaluation of the guidelines for management of pancreatic branch-duct intraductal papillary mucinous neoplasm. Clinical Gastroenterology and Hepatology 6(7): 815-9; Quiz 719, 2008

Evaluation Of The Consensus Guidelines For The Operative Management Of Side Branch Intraductal Papillary Mucinous Neoplasm Of Pancreas. Pancreas 35(4): 430-431, 2007

Exam 2: Evaluation of the Guidelines for Operative Management of Pancreatic Branch-Duct Intraductal Papillary Mucinous Neoplasm. Clinical Gastroenterology and Hepatology 6(7): 719-719, 2008

Intraductal papillary mucinous neoplasms of the pancreas - a cost-effectiveness analysis of management strategies for the branch-duct subtype. Hpb 20(12): 1206-1214, 2018

Tu1510 Validation of the International Consensus Guidelines for Branch Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Meta-Analysis. Gastroenterology 142(5): S-852-S-853, 2012

Validation of the 2012 International Consensus Guidelines Using CT and MRI: Branch Duct and Main Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas. Annals of Surgery 266(6): E51-E52, 2017

Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients. American Journal of Gastroenterology 102(8): 1759-1764, 2007

Validation of international consensus guidelines for the resection of branch duct-type intraductal papillary mucinous neoplasms. British Journal of Surgery 101(6): 686-692, 2014

Utility of the sendai consensus guidelines for branch-duct intraductal papillary mucinous neoplasms: a systematic review. Journal of Gastrointestinal Surgery 18(7): 1350-1357, 2014

Identifying a mucinous neoplasm utilizing confocal laser endomicroscopy: branch-duct gastric type intraductal papillary mucinous neoplasm. Journal of Gastrointestinal and Liver Diseases 26(3): 224, 2017

Comparison between mucinous cystic neoplasm and intraductal papillary mucinous neoplasm of the branch duct type of the pancreas with respect to expression of CD10 and cytokeratin 20. Pancreas 38(5): 558-564, 2009

Concurrent presentation of an intraductal tubulopapillary neoplasm and intraductal papillary mucinous neoplasm in the branch duct of the pancreas, with a superior mesenteric artery aneurysm: a case report. World Journal of Surgical Oncology 16(1): 83, 2018

S1297 When to Operate or Observe Branch Duct Intraductal Papillary Mucinous Neoplasms (Ipmn-Br): Evaluation of Consensus Guidelines. Gastroenterology 136(5): A-232, 2009